Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
Fig. 3 I
Pera EM et al. (2024)
|
Xla Wt + htra1
NF20 (in situ hybridization)
|
|
|
|
FIG. 2 MP
Pera EM et al. (2024)
|
Xla Wt + serpine2 MO
NF20 (in situ hybridization)
|
|
|
|
Fig. 2 de
Alasaadi DN et al. (2024)
|
Xla Wt + deflation
NF15 (in situ hybridization)
|
|
|
|
Fig. 2 de
Alasaadi DN et al. (2024)
|
Xla Wt + Inflation
NF15 (in situ hybridization)
|
|
|
|
Fig. 2 B
Ismail T et al. (2024)
|
Xla Wt +PFOS
NF35/36-37/38 (RNA-Seq)
|
|
|
|
Fig. S3 ABCD
Yamamoto T et al. (2023)
|
Xla Wt + hs6st1 CRISPR
NF17-18 (in situ hybridization)
|
|
|
|
Fig. 2 B r1, C; B r2, C
Yamamoto T et al. (2023)
|
Xla Wt + hs6st1.L
NF15 (in situ hybridization)
|
|
|
|
Fig. 5A
Job F et al. (2023)
|
Xla Wt + otud3 MO
NF20 (in situ hybridization)
|
|
|
|
Fig. 3 a row1
Ihewulezi C and Saint-Jeannet JP (2021)
|
Xla Wt + hmgn1 MO
NF15 (in situ hybridization)
|
|
|
|
Fig.4.L-O,V
Tavares ALP et al. (2021)
|
Xla Wt + sobp
NF16-18 (in situ hybridization)
|
|
|